Last reviewed · How we verify

NCT07110324: PAIN-COMPO

Characteristics of Persistent Pain Composition Following Total Hip or Knee Arthroplasty: a Descriptive Study

Recruiting now Last updated 1 April 2026
What this trial tests

trial in Pain (Visceral, Somatic, or Neuropathic) in 100 participants. Currently enrolling.

Timeline
26 June 2025
Primary endpoint
1 December 2026
1 December 2026

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment100
Start date26 June 2025
Primary completion1 December 2026
Estimated completion1 December 2026
Sites1 location across Denmark

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Pain (Visceral, Somatic, or Neuropathic) or Hip Arthroplasty Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite high success rates of hip and knee arthroplasty, up to 20% of patients report moderate-to-severe pain (NRS \> 3) persisting beyond the expected healing period. This investigator-initiated, descriptive cohort study will re-invite approximately 100 consenting patients with persistent postoperative pain-identified from a pool of \~7 000 respondents-to complete standardized assessments of neuropathic (DN4), nociplastic (IASP criteria + Fibromyalgia Survey Questionnaire) and nociceptive (KOOS/HOOS pain domains) pain. Primary outcomes are the prevalence of potential nociplastic pain and the proportion experiencing significant pain in two or more mechanistic categories. Secondary analyses will compare baseline vs. re-evaluated DN4 scores, FSQ and KOOS/HOOS distributions, and examine differences between patients with and without possible neuropathic pain. Findings will inform targeted pre- and postoperative pain management strategies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain (Visceral, Somatic, or Neuropathic)

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07110324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing